PMC:7335697 / 20006-20769 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T154","span":{"begin":75,"end":83},"obj":"Disease"},{"id":"T155","span":{"begin":550,"end":554},"obj":"Disease"}],"attributes":[{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Study population Results\nPatients, n 57\nMedications, n (%)\nSteroids (for COVID-19) 19 (35)\nAntibiotics 35 (63)\n Azitromycin 15 (27)\n \u003e1 antibiotic 16 (29)\nAntivirals 5 (9)\n Lopinavir/ritonavir 3 (5)\n Darunavir/cobicistat 1 (2)\n Remdesivir 1 (2)\nImmunomodulator 3 (5)\n Tocilizumab 1 (2)\n Rituximab 1 (2)\n Ruxolitinib 1 (2)\nHydroxychloroquine 24 (44)\nOxygen therapy (higher intensity), n (%)\nOverall 30 (54)\n Nasal cannula 18 (32)\n Non-invasive ventilation 8 (14)\n Invasive mechanical ventilation 4 (7)\nOutcomes, n (%)\nDeath 7 (12)\nARDS 11 (19)\nICU admission 4 (7)\nHospitalisation (no ICU) 37 (65)\n Need for rehabilitation 7 (17)\nDuration of hospitalisation, median (IQR)\nHospital stay 10 (7–22)\n ICU stay 16 (10–19)\nRehab stay 14 (11–15)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T200","span":{"begin":90,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T201","span":{"begin":107,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T202","span":{"begin":133,"end":135},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T203","span":{"begin":201,"end":206},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T204","span":{"begin":272,"end":277},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T205","span":{"begin":438,"end":440},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T206","span":{"begin":556,"end":558},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T207","span":{"begin":715,"end":717},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T208","span":{"begin":757,"end":759},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Study population Results\nPatients, n 57\nMedications, n (%)\nSteroids (for COVID-19) 19 (35)\nAntibiotics 35 (63)\n Azitromycin 15 (27)\n \u003e1 antibiotic 16 (29)\nAntivirals 5 (9)\n Lopinavir/ritonavir 3 (5)\n Darunavir/cobicistat 1 (2)\n Remdesivir 1 (2)\nImmunomodulator 3 (5)\n Tocilizumab 1 (2)\n Rituximab 1 (2)\n Ruxolitinib 1 (2)\nHydroxychloroquine 24 (44)\nOxygen therapy (higher intensity), n (%)\nOverall 30 (54)\n Nasal cannula 18 (32)\n Non-invasive ventilation 8 (14)\n Invasive mechanical ventilation 4 (7)\nOutcomes, n (%)\nDeath 7 (12)\nARDS 11 (19)\nICU admission 4 (7)\nHospitalisation (no ICU) 37 (65)\n Need for rehabilitation 7 (17)\nDuration of hospitalisation, median (IQR)\nHospital stay 10 (7–22)\n ICU stay 16 (10–19)\nRehab stay 14 (11–15)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T100","span":{"begin":141,"end":151},"obj":"Chemical"},{"id":"T101","span":{"begin":180,"end":189},"obj":"Chemical"},{"id":"T102","span":{"begin":190,"end":199},"obj":"Chemical"},{"id":"T103","span":{"begin":208,"end":217},"obj":"Chemical"},{"id":"T104","span":{"begin":218,"end":228},"obj":"Chemical"},{"id":"T105","span":{"begin":364,"end":370},"obj":"Chemical"}],"attributes":[{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_72291"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_15379"}],"text":"Study population Results\nPatients, n 57\nMedications, n (%)\nSteroids (for COVID-19) 19 (35)\nAntibiotics 35 (63)\n Azitromycin 15 (27)\n \u003e1 antibiotic 16 (29)\nAntivirals 5 (9)\n Lopinavir/ritonavir 3 (5)\n Darunavir/cobicistat 1 (2)\n Remdesivir 1 (2)\nImmunomodulator 3 (5)\n Tocilizumab 1 (2)\n Rituximab 1 (2)\n Ruxolitinib 1 (2)\nHydroxychloroquine 24 (44)\nOxygen therapy (higher intensity), n (%)\nOverall 30 (54)\n Nasal cannula 18 (32)\n Non-invasive ventilation 8 (14)\n Invasive mechanical ventilation 4 (7)\nOutcomes, n (%)\nDeath 7 (12)\nARDS 11 (19)\nICU admission 4 (7)\nHospitalisation (no ICU) 37 (65)\n Need for rehabilitation 7 (17)\nDuration of hospitalisation, median (IQR)\nHospital stay 10 (7–22)\n ICU stay 16 (10–19)\nRehab stay 14 (11–15)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"522","span":{"begin":26,"end":34},"obj":"Species"},{"id":"523","span":{"begin":180,"end":199},"obj":"Chemical"},{"id":"524","span":{"begin":237,"end":247},"obj":"Chemical"},{"id":"525","span":{"begin":75,"end":83},"obj":"Disease"},{"id":"526","span":{"begin":536,"end":541},"obj":"Disease"},{"id":"527","span":{"begin":550,"end":554},"obj":"Disease"}],"attributes":[{"id":"A522","pred":"tao:has_database_id","subj":"522","obj":"Tax:9606"},{"id":"A523","pred":"tao:has_database_id","subj":"523","obj":"MESH:C558899"},{"id":"A524","pred":"tao:has_database_id","subj":"524","obj":"MESH:C000606551"},{"id":"A525","pred":"tao:has_database_id","subj":"525","obj":"MESH:C000657245"},{"id":"A526","pred":"tao:has_database_id","subj":"526","obj":"MESH:D003643"},{"id":"A527","pred":"tao:has_database_id","subj":"527","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Study population Results\nPatients, n 57\nMedications, n (%)\nSteroids (for COVID-19) 19 (35)\nAntibiotics 35 (63)\n Azitromycin 15 (27)\n \u003e1 antibiotic 16 (29)\nAntivirals 5 (9)\n Lopinavir/ritonavir 3 (5)\n Darunavir/cobicistat 1 (2)\n Remdesivir 1 (2)\nImmunomodulator 3 (5)\n Tocilizumab 1 (2)\n Rituximab 1 (2)\n Ruxolitinib 1 (2)\nHydroxychloroquine 24 (44)\nOxygen therapy (higher intensity), n (%)\nOverall 30 (54)\n Nasal cannula 18 (32)\n Non-invasive ventilation 8 (14)\n Invasive mechanical ventilation 4 (7)\nOutcomes, n (%)\nDeath 7 (12)\nARDS 11 (19)\nICU admission 4 (7)\nHospitalisation (no ICU) 37 (65)\n Need for rehabilitation 7 (17)\nDuration of hospitalisation, median (IQR)\nHospital stay 10 (7–22)\n ICU stay 16 (10–19)\nRehab stay 14 (11–15)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T244","span":{"begin":0,"end":25},"obj":"Sentence"},{"id":"T245","span":{"begin":26,"end":41},"obj":"Sentence"},{"id":"T246","span":{"begin":42,"end":60},"obj":"Sentence"},{"id":"T247","span":{"begin":61,"end":93},"obj":"Sentence"},{"id":"T248","span":{"begin":94,"end":114},"obj":"Sentence"},{"id":"T249","span":{"begin":115,"end":136},"obj":"Sentence"},{"id":"T250","span":{"begin":137,"end":160},"obj":"Sentence"},{"id":"T251","span":{"begin":161,"end":178},"obj":"Sentence"},{"id":"T252","span":{"begin":179,"end":206},"obj":"Sentence"},{"id":"T253","span":{"begin":207,"end":235},"obj":"Sentence"},{"id":"T254","span":{"begin":236,"end":254},"obj":"Sentence"},{"id":"T255","span":{"begin":255,"end":277},"obj":"Sentence"},{"id":"T256","span":{"begin":278,"end":297},"obj":"Sentence"},{"id":"T257","span":{"begin":298,"end":315},"obj":"Sentence"},{"id":"T258","span":{"begin":316,"end":335},"obj":"Sentence"},{"id":"T259","span":{"begin":336,"end":363},"obj":"Sentence"},{"id":"T260","span":{"begin":364,"end":404},"obj":"Sentence"},{"id":"T261","span":{"begin":405,"end":421},"obj":"Sentence"},{"id":"T262","span":{"begin":422,"end":445},"obj":"Sentence"},{"id":"T263","span":{"begin":446,"end":479},"obj":"Sentence"},{"id":"T264","span":{"begin":480,"end":519},"obj":"Sentence"},{"id":"T265","span":{"begin":520,"end":535},"obj":"Sentence"},{"id":"T266","span":{"begin":536,"end":549},"obj":"Sentence"},{"id":"T267","span":{"begin":550,"end":563},"obj":"Sentence"},{"id":"T268","span":{"begin":564,"end":584},"obj":"Sentence"},{"id":"T269","span":{"begin":585,"end":618},"obj":"Sentence"},{"id":"T270","span":{"begin":619,"end":651},"obj":"Sentence"},{"id":"T271","span":{"begin":652,"end":693},"obj":"Sentence"},{"id":"T272","span":{"begin":694,"end":718},"obj":"Sentence"},{"id":"T273","span":{"begin":719,"end":740},"obj":"Sentence"},{"id":"T274","span":{"begin":741,"end":763},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Study population Results\nPatients, n 57\nMedications, n (%)\nSteroids (for COVID-19) 19 (35)\nAntibiotics 35 (63)\n Azitromycin 15 (27)\n \u003e1 antibiotic 16 (29)\nAntivirals 5 (9)\n Lopinavir/ritonavir 3 (5)\n Darunavir/cobicistat 1 (2)\n Remdesivir 1 (2)\nImmunomodulator 3 (5)\n Tocilizumab 1 (2)\n Rituximab 1 (2)\n Ruxolitinib 1 (2)\nHydroxychloroquine 24 (44)\nOxygen therapy (higher intensity), n (%)\nOverall 30 (54)\n Nasal cannula 18 (32)\n Non-invasive ventilation 8 (14)\n Invasive mechanical ventilation 4 (7)\nOutcomes, n (%)\nDeath 7 (12)\nARDS 11 (19)\nICU admission 4 (7)\nHospitalisation (no ICU) 37 (65)\n Need for rehabilitation 7 (17)\nDuration of hospitalisation, median (IQR)\nHospital stay 10 (7–22)\n ICU stay 16 (10–19)\nRehab stay 14 (11–15)"}